Your browser doesn't support javascript.
loading
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma.
Lopez, Juanita; Lai-Kwon, Julia; Molife, Rhoda; Welsh, Liam; Tunariu, Nina; Roda, Desamparados; Fernández-García, Paula; Lladó, Victoria; McNicholl, Adrian G; Rosselló, Catalina A; Taylor, Richard J; Azaro, Analía; Rodón, Jordi; Sludden, Julieann; Veal, Gareth J; Plummer, Ruth; Urruticoechea, Ander; Lahuerta, Ainhara; Mujika, Karmele; Escribá, Pablo V.
Affiliation
  • Lopez J; The Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. Juanita.Lopez@icr.ac.uk.
  • Lai-Kwon J; The Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK.
  • Molife R; The Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK.
  • Welsh L; The Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK.
  • Tunariu N; The Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK.
  • Roda D; The Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK.
  • Fernández-García P; Laminar Pharmaceuticals, Palma de Mallorca, Spain.
  • Lladó V; Laminar Pharmaceuticals, Palma de Mallorca, Spain.
  • McNicholl AG; Laminar Pharmaceuticals, Palma de Mallorca, Spain.
  • Rosselló CA; Laminar Pharmaceuticals, Palma de Mallorca, Spain.
  • Taylor RJ; Laminar Pharmaceuticals, Palma de Mallorca, Spain.
  • Azaro A; Hospital Vall d'Hebrón, Barcelona, Spain.
  • Rodón J; Hospital Vall d'Hebrón, Barcelona, Spain.
  • Sludden J; Northern Centre for Cancer Care, Newcastle upon Tyne, UK.
  • Veal GJ; Northern Centre for Cancer Care, Newcastle upon Tyne, UK.
  • Plummer R; Northern Centre for Cancer Care, Newcastle upon Tyne, UK.
  • Urruticoechea A; Gipuzkoa Cancer Unit, OSID-Onkologikoa, San Sebastián, Spain.
  • Lahuerta A; Gipuzkoa Cancer Unit, OSID-Onkologikoa, San Sebastián, Spain.
  • Mujika K; Gipuzkoa Cancer Unit, OSID-Onkologikoa, San Sebastián, Spain.
  • Escribá PV; Laminar Pharmaceuticals, Palma de Mallorca, Spain.
Br J Cancer ; 129(5): 811-818, 2023 09.
Article in En | MEDLINE | ID: mdl-37488446
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioma / Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Br J Cancer Year: 2023 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioma / Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Br J Cancer Year: 2023 Document type: Article Affiliation country: United kingdom